Status:
COMPLETED
Respiratoy Muscle Strength in Patients With Multiple System Atrophy
Lead Sponsor:
Marmara University
Conditions:
Multiple System Atrophy
Eligibility:
All Genders
40-85 years
Phase:
NA
Brief Summary
The purpose of this study is; compare respiratory function parameters and respiratory muscle strength in patients with MSA compare to healthy controls, and to evaluate the results of SNIP and PImax in...
Detailed Description
Multiple system atrophy (MSA) is a sporadic, neurodegenerative disease that begins in adulthood, progressive, unexplained. Brain stem degeneration is thought to play a role in respiratory symptoms suc...
Eligibility Criteria
Inclusion
- Being between 40-80 years old
- Have been diagnosed with MSA
- Being under drug treatment
- Being enlightened to participate in the study and filling in the consent form
- Respiratory disease or no history of occupational exposure to affect the respiratory system
- The absence of any physical or mental disability that will prevent the implementation of the tests
- Mini Mental Test score\> 24
Exclusion
- Any history of neuromuscular disease other than MSA
- Having a diagnosis of psychiatric illness
- Chronic obstructive pulmonary disease (COPD) diagnosis
- The patient is not cooperative
- dementia
- Nasal congestion
Key Trial Info
Start Date :
February 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 26 2021
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04287270
Start Date
February 2 2019
End Date
February 26 2021
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University Faculty of Health Sciences
Istanbul, Maltepe, Turkey (Türkiye)